Innoviva, Inc. (INVA)
20.77
-0.20
(-0.95%)
USD |
NASDAQ |
Aug 31, 16:00
20.78
+0.01
(+0.05%)
After-Hours: 20:00
Innoviva Total Long Term Debt (Quarterly) : 268.94M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 268.94M |
| March 31, 2026 | 326.08M |
| December 31, 2025 | 268.60M |
| September 30, 2025 | 258.28M |
| June 30, 2025 | 324.44M |
| March 31, 2025 | 257.76M |
| December 31, 2024 | 257.50M |
| September 30, 2024 | 257.56M |
| June 30, 2024 | 449.26M |
| March 31, 2024 | 448.06M |
| December 31, 2023 | 447.87M |
| September 30, 2023 | 517.79M |
| June 30, 2023 | 517.44M |
| March 31, 2023 | 446.79M |
| December 31, 2022 | 613.34M |
| September 30, 2022 | 618.23M |
| June 30, 2022 | 542.34M |
| March 31, 2022 | 542.05M |
| December 31, 2021 | 394.65M |
| September 30, 2021 | 392.30M |
| June 30, 2021 | 389.99M |
| March 31, 2021 | 387.73M |
| December 31, 2020 | 385.52M |
| September 30, 2020 | 383.35M |
| June 30, 2020 | 381.23M |
| Date | Value |
|---|---|
| March 31, 2020 | 379.15M |
| December 31, 2019 | 377.22M |
| September 30, 2019 | 388.84M |
| June 30, 2019 | 387.83M |
| March 31, 2019 | 385.98M |
| December 31, 2018 | 383.36M |
| September 30, 2018 | 381.00M |
| June 30, 2018 | 486.53M |
| March 31, 2018 | 484.59M |
| December 31, 2017 | 599.36M |
| September 30, 2017 | 603.45M |
| June 30, 2017 | 653.89M |
| March 31, 2017 | 709.03M |
| December 31, 2016 | 716.09M |
| September 30, 2016 | 723.00M |
| June 30, 2016 | 722.29M |
| March 31, 2016 | 734.51M |
| December 31, 2015 | 748.27M |
| September 30, 2015 | 744.08M |
| June 30, 2015 | 738.47M |
| March 31, 2015 | 732.06M |
| December 31, 2014 | 725.64M |
| September 30, 2014 | 705.11M |
| June 30, 2014 | 737.50M |
| March 31, 2014 | 287.50M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 0.87M |
| Collegium Pharmaceutical, Inc. | 1.216B |
| CorMedix, Inc. | 145.15M |
| ANI Pharmaceuticals, Inc. | 610.49M |
| Corcept Therapeutics, Inc. | 7.504M |